Books on the topic 'Mifepristone'

International Society of Gynecological Endocrinology. RU 486 principales données bibliographiques cliniques. Brussels, Belgium: International Society of Gynecological Endocrinology, 1989.

Cominsky, Karl J. Abortion and RU-486--Mifepristone: Index of new information and research bible. Washington, D.C: Abbe Publishers Association of Washington, D.C., 1995.

H, Miles Steven, ed. RU-486: New issues in the American abortion debate. Minneapolis, MN: Center for Biomedical Ethics, 1990.

Costa, Caroline De. RU-486: The abortion pill. Salisbury, Qld: Boolarong Press, 2007.

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Energy. The safety and effectiveness of the abortifacient RU486 in foreign markets: Opportunities and obstacles to U.S. commercialization : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, first session, Washington, DC, December 5, 1991. Washington: U.S. G.P.O., 1992.

International Symposium on Antiprogestins (1992? Bangladesh Association for Prevention of Septic Abortion). Proceedings of the International Symposium on Antiprogestins. Dhaka: Bangladesh Association for Prevention of Septic Abortion, 1992.

Lee, Sile. Apples like broken glass / decisive. New York, NY?: The author, 2008.

Chalker, Rebecca. A woman's book of choices: Abortion, menstrual extraction, RU-486. New York: Four Walls Eight Windows, 1992.

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology. RU-486, status report on the U.S. commercialization project, transfer of antiprogestin technology to the United States: Hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, second session, Washington, DC, May 16, 1994. Washington: U.S. G.P.O., 1994.

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology. RU-486, status report on the U.S. commercialization project, transfer of antiprogestin technology to the United States: Hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, second session, Washington, DC, May 16, 1994. Washington: U.S. G.P.O., 1994.

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology. RU-486, status report on the U.S. commercialization project, transfer of antiprogestin technology to the United States: Hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, second session, Washington, DC, May 16, 1994. Washington: U.S. G.P.O., 1994.

Tambone, Vittoradolfo. Valutazione morale dell'uso abortivo e clinico della RU 486. Romae: Pontificia Universitas Sanctae Crucis, Facultas Theologiae, 1999.

Asbury, Beverly A. RU 486 and the transforming of a debate. Nashville, TN: Board of Higher Education and Ministry, the United Methodist Church, 1987.

Z, Benet Leslie, Donaldson Molla S, Institute of Medicine (U.S.). Committee on Antiprogestins: Assessing the Science., and Institute of Medicine (U.S.). Division of Health Promotion and Disease Prevention., eds. Clinical applications of mifepristone (RU 486) and other antiprogestins: Assessing the science and recommending a research agenda. Washington, D.C: National Academy Press, 1993.

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Energy. The effect of federal ban of RU 486 on medical research, new drug development, and pharmaceutical manufacturers: Hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, second session, Washington, DC, July 28, 1992. Washington: U.S. G.P.O., 1993.

Cavoni, Cesare Davide. La vera storia della pillola abortiva RU 486. Siena: Cantagalli, 2008.

Cerys, Williams, and Birth Control Trust, eds. The "Abortion pill" (mifepristone/RU486): Widening the choice for women : proceedings of a conference organised by the Birth Control Trust on 26 October 1989 at the Royal College of Obstetricians and Gynaecologists, London. London: Birth Control Trust, 1990.

Lader, Lawrence. RU 486: The pill that could end the abortion wars and why American women don't have it. Reading, Mass: Addison-Wesley Pub. Co., 1991.

Conference on the Antiprogestational Compound RU 486 (1984 Bellagio, Italy). The antiprogestin steroid RU 486 and human fertility control. New York: Plenum Press, 1985.

Columbia, Reproductive Justice. A Guide to Medication Abortion for Barnumbia. New York, NY: Reproductive Justice Columbia, 2022.

Institute, Alan Guttmacher, ed. RU 486: The science and the politics. New York, NY (111 Fifth Ave., New York 10003): Alan Guttmacher Institute, 1989.

Baulieu, Etienne-Emile. The "abortion pill": RU-486, a woman's choice. New York: Simon & Schuster, 1991.

Tambone, V. Valutazione morale dell'uso abortivo e clinico della RU 486. Romae: Società editrice universo, 1999.

United, States Congress House Committee on Small Business Subcommittee on Regulation Business Opportunities and Energy. RU 486: The import ban and its effect on medical research : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred First Congress, second session, Washington, DC, November 19, 1990. Washington: U.S. G.P.O., 1991.

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Energy. RU 486: The import ban and its effect on medical research : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred First Congress, second session, Washington, DC, November 19, 1990. Washington: U.S. G.P.O., 1991.

Riddle, John M. Contraception and Abortion from the Ancient World to the Renaissance. Cambridge, Mass: Harvard U.P., 1992.

Ochsenkühn, Robert. Auswirkung der Antigestagene Mifepriston (RU486) und Onapriston (ZK98299) sowie des Gestagenagonisten Promegeston (R5020) auf die Prostaglandinsynthese (PGF2[alpha], PGE2) menschlicher Granulosazellkulturen. [s.l.]: [s.n.], 1997.

Susan, Queen. Mifepristone. Blurb, 2019.

Craig, Arthur. Mifepristone. Independently Published, 2019.

Steve, Job. Mifepristone. Blurb, 2019.

Erin, Jesse. Using Mifepristone: All You Need to Know about Mifepristone Before Using It for Abortion. Independently Published, 2022.

Randy, Albert. Mifepristone: The Complete Guide on Using Mifepristone Abortion Pill During the Early Part of Pregnancy. Independently Published, 2022.

Theo, Liam. Mifepristone for Abortion: A Step to Step Guide on How to Use Mifepristone Pills to Eliminate Pregnancy. Independently Published, 2022.

Clinical Applications of Mifepristone (RU486) and Other Antiprogestins. Washington, D.C.: National Academies Press, 1993. http://dx.doi.org/10.17226/2203.

Mifepristone: Pharmacology, Medical Uses and Potential Side Effects. Nova Science Pub Inc, 2014.

Abortion Pill Zine: A Community Guide to Misoprostol and Mifepristone. Silver Sprocket, 2024.

Clinical applications of mifepristone (RU 486) and other antiprogestins: Assessing thescience and recommending a research agenda. Washington, D.C: National Academy Press, 1993.

Cominsky. Abortion and Ru-486 (Mifepristone : Index of New Information & Research Bible). Abbe Pub Assn of Washington Dc, 1994.

Cominsky. Abortion and Ru-486 (Mifepristone : Index of New Information & Research Bible). Abbe Pub Assn of Washington Dc, 1994.

Publications, ICON Health. Mifepristone - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References. ICON Health Publications, 2004.

The Development and use of antiprogestin drugs: Social, political, economic, and legal issues. Boston, MA: Medicine in the Public Interest, 1992.

Herbert, Barbara, Barbara Ehrenreich, Carol Downer, and Rebecca Chalker. Woman's Book of Choices: Abortion, Menstrual Extraction, RU-486. Seven Stories Press, 2011.

Baulieu, Etienne-Emile. The Antiprogestin Steroid RU 486 and Human Fertility Control. Springer, 2012.

Baulieu, Etienne-Emile. Antiprogestin Steroid RU 486 and Human Fertility Control. Springer London, Limited, 2013.

Grant, George. The Quick and the Dead: Ru 486 and the New Chemical Warfare Against Your Family. Crossway Books, 1992.

Carron, Peter. Mifepristone: The POTENT ACTIVE TREATMENT for ENDING TRIMESTER PREGNANCY and ULCER - Buy Now! Independently Published, 2019.

Quick, William S. Mifepristone: The Ultimate Guide to End Unwanted Pregnancy Safely, Completely and Without Complications. Independently Published, 2022.

iduh, precious. Mifepristone: The SUPER ACTIVE TREATMENT for ULCERS and END PREGNANCY. Grab Yours Now!!! Independently Published, 2019.

RU-486: Demonstrating a low standard for women's health? : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, second session, May 17, 2006. Washington: U.S. G.P.O., 2007.

Klein, Renate, Lynette J. Dumble, and Janice G. Raymond. Ru 486 Misconceptions Myths and Morals. Spinifex Pr, 1992.